Orgenesis and UC Davis partner on decentralized development and manufacturing of CGTs
Orgenesis is pairing up with University of California, Davis (UC Davis) to deploy cell and gene therapy mobile processing units and labs across California.
Archives for March 20, 2023
Vaxart reduces workforce and pauses COVID-19 vaccine development
The developer of oral vaccines announces a restructure of its business priorities, as it looks to conserve cash to progress its norovirus candidate.
Novartis releases long-term Zolgensma data
Novartis has presented new data which ‘underscore the transformational and sustained benefit’ of spinal muscular atrophy (SMA) gene therapy Zolgensma (onasemnogene abeparvovec): with treated children maintaining motor milestones after 7.5 years.
Samsung Biologics to start construction of Plant 5
Samsung Biologics will begin construction of Plant 5 within the first half of this year: marking the first facility for its second Bio Campus.
Teknova and Sartorius look to address critical pain points in AAV bioprocessing
Alpha Teknova Inc is teaming up with Sartorius BIA Separations, part of the Sartorius life sciences group, to help gene therapy companies streamline the downstream purification process.